NCT00030173View on ClinicalTrials.gov

A Trial to Evaluate Epothilone D in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

June 30, 2003

Conditions
Neoplasms
Interventions
DRUG

Epothilone D (KOS-862)

Trial Locations (1)

90095-7059

UCLA Medical Center, Los Angeles

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY